FOLD logo

Amicus Therapeutics (FOLD) Return On Assets

Annual ROA

-20.18%
+8.86%+30.51%

31 December 2023

FOLD ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROA

-13.78%
+2.19%+13.71%

30 September 2024

FOLD Quarterly ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FOLD ROA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+32.8%
3 y3 years+27.8%+52.2%
5 y5 years+53.6%+67.5%

FOLD ROA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+30.5%at high+58.0%
5 y5 yearsat high+53.6%at high+67.5%
alltimeall time-229.2%+98.5%-153.3%+90.1%

Amicus Therapeutics ROA History

DateAnnualQuarterly
Sept 2024
-
-13.78%(-13.7%)
June 2024
-
-15.97%(-19.7%)
Mar 2024
-
-19.90%(-2.9%)
Dec 2023
-20.18%(-30.5%)
-20.50%(-13.1%)
Sept 2023
-
-23.60%(-5.4%)
June 2023
-
-24.94%(-6.9%)
Mar 2023
-
-26.79%(-9.0%)
Dec 2022
-29.04%(+3.9%)
-29.45%(-5.2%)
Sept 2022
-
-31.06%(-5.4%)
June 2022
-
-32.85%(+4.3%)
Mar 2022
-
-31.51%(+9.3%)
Dec 2021
-27.96%(-12.3%)
-28.82%(+4.9%)
Sept 2021
-
-27.48%(-11.0%)
June 2021
-
-30.88%(-1.7%)
Mar 2021
-
-31.41%(-7.5%)
Dec 2020
-31.88%(-26.6%)
-33.95%(-6.3%)
Sept 2020
-
-36.24%(+1.2%)
June 2020
-
-35.81%(-8.5%)
Mar 2020
-
-39.13%(-7.6%)
Dec 2019
-43.46%(-11.8%)
-42.37%(+3.1%)
Sept 2019
-
-41.10%(-23.1%)
June 2019
-
-53.43%(+4.2%)
Mar 2019
-
-51.28%(+16.1%)
Dec 2018
-49.26%(+44.3%)
-44.16%(-0.2%)
Sept 2018
-
-44.26%(+19.3%)
June 2018
-
-37.11%(+9.4%)
Mar 2018
-
-33.93%(+2.2%)
Dec 2017
-34.14%(+66.0%)
-33.20%(+10.9%)
Sept 2017
-
-29.93%(+37.9%)
June 2017
-
-21.71%(-2.9%)
Mar 2017
-
-22.36%(+3.8%)
Dec 2016
-20.57%(-12.9%)
-21.55%(+7.4%)
Sept 2016
-
-20.07%(-6.7%)
June 2016
-
-21.52%(-4.7%)
Mar 2016
-
-22.58%(-7.6%)
Dec 2015
-23.63%
-24.45%(-15.0%)
Sept 2015
-
-28.78%(-32.7%)
June 2015
-
-42.76%(-16.1%)
DateAnnualQuarterly
Mar 2015
-
-50.94%(+2.5%)
Dec 2014
-40.84%(-18.6%)
-49.70%(-8.4%)
Sept 2014
-
-54.25%(-3.7%)
June 2014
-
-56.33%(-6.1%)
Mar 2014
-
-59.97%(-3.0%)
Dec 2013
-50.19%(-7.5%)
-61.82%(+1.9%)
Sept 2013
-
-60.69%(+5.8%)
June 2013
-
-57.34%(+19.6%)
Mar 2013
-
-47.94%(+4.3%)
Dec 2012
-54.24%(+11.4%)
-45.98%(-3.2%)
Sept 2012
-
-47.50%(+9.5%)
June 2012
-
-43.39%(-9.2%)
Mar 2012
-
-47.80%(-2.3%)
Dec 2011
-48.71%(-12.3%)
-48.91%(-13.8%)
Sept 2011
-
-56.74%(-10.7%)
June 2011
-
-63.55%(+1.9%)
Mar 2011
-
-62.36%(-3.6%)
Dec 2010
-55.51%(+805.5%)
-64.68%(+671.8%)
Sept 2010
-
-8.38%(+54.0%)
June 2010
-
-5.44%(-25.6%)
Mar 2010
-
-7.31%(+19.8%)
Dec 2009
-6.13%(-77.0%)
-6.10%(-86.5%)
Sept 2009
-
-45.04%(+20.6%)
June 2009
-
-37.36%(+18.4%)
Mar 2009
-
-31.55%(+16.8%)
Dec 2008
-26.60%(+8.0%)
-27.02%(+13.4%)
Sept 2008
-
-23.82%(-8.2%)
June 2008
-
-25.96%(-3.5%)
Mar 2008
-
-26.90%(-18.9%)
Dec 2007
-24.64%(-68.3%)
-33.16%(-21.3%)
Sept 2007
-
-42.13%(-12.2%)
June 2007
-
-47.98%(-28.4%)
Mar 2007
-
-67.00%(-13.8%)
Dec 2006
-77.70%(+11.5%)
-77.70%(-44.0%)
Sept 2006
-
-138.65%(+19.9%)
June 2006
-
-115.66%(+24.8%)
Mar 2006
-
-92.66%(+33.0%)
Dec 2005
-69.66%(-94.8%)
-69.66%
Dec 2003
-1350.90%
-

FAQ

  • What is Amicus Therapeutics annual return on assets?
  • What is the all time high annual ROA for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly ROA year-on-year change?

What is Amicus Therapeutics annual return on assets?

The current annual ROA of FOLD is -20.18%

What is the all time high annual ROA for Amicus Therapeutics?

Amicus Therapeutics all-time high annual return on assets is -6.13%

What is Amicus Therapeutics quarterly return on assets?

The current quarterly ROA of FOLD is -13.78%

What is the all time high quarterly ROA for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly return on assets is -5.44%

What is Amicus Therapeutics quarterly ROA year-on-year change?

Over the past year, FOLD quarterly return on assets has changed by +6.72% (+32.78%)